|
Tuesday, March 20 — 8:00 AM — CC Ballroom C
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - Breast Pathology
Chaired by: Adriana Corben and Dhananjay Arun Chitale
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Characterisation of the Repertoire of Gene Copy Number Changes and Gene Mutations in the Progression from In Situ to Invasive Breast Cancer
(103)
A Campion-Flora, L Hernandez, P Wilkerson, MB Lambros, DN Rodrigues, A Gauthier, A Mackay, R Natrajan, JS Reis- Filho - The Institute of Cancer Research, London, United Kingdom; Institut Curie, Paris, France
|  Add |
| 8:15 |
Comprehensive Genomic Profiling of Breast Cancer by Massively Parallel Sequencing Reveals New Routes to Targeted Therapies
(253)
J Ross, C Sheehan, A Parker, M Jarosz, S Downing, R Yelensky, D Lipson, P Stephens, G Palmer, M Cronin - Albany Medical College, Albany, NY; Foundation Medicine Inc., Cambridge, MA
| Add |
| 8:30 |
Prediction of Oncotype DX Recurrence Score: Use of Equations Derived by Linear Regression Analysis
(182)
ME Klein, DJ Dabbs, Y Shuai, R Bhargava - University of Wisconsin, Madison, WI; Magee-Womens Hospital of UPMC, Pittsburgh, PA; University of Pittsburgh Cancer Institute, Pittsburgh, PA
| Add |
| 8:45 |
Breast Micropapillary Carcinomas: RNA-Seq and Mutation Profiling
(207)
C Marchio, DN Rodrigues, P Wilkerson, MB Lambros, B Weigelt, A Sapino, A Mackay, C Maher, R Natrajan, JS Reis- Filho - University of Turin, Turin, Italy; The Institute of Cancer Research, London, United Kingdom; Cancer Research UK London Research Institute, London, United Kingdom; Washington University School of Medicine, St Louis
| Add |
| 9:00 |
The Predictive Value of P53 Expression to Anthracycline-Based Neo-Adjuvant Therapy in Triple Negative Breast Cancer Patients
(301)
JT Yang, CZ Liu, W Dooley, R Squires, E Jett, J Parker - OUHSC, Oklahoma City, OK
| Add |
| 9:15 |
High Concordance between HercepTest IHC and HER2 FISH: An Analysis of Two Companion Diagnostic Tests before and after Implementation of ASCO/CAP 2007 Guidelines
(287)
ME Vergara-Lluri, NA Moatamed, SK Apple - David Geffen UCLA Medical Center, Los Angeles, CA
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
Concordance of Tumor Grade, ER and Her2+ER- Status with Gene-Expression-Based Profile Studies: Boosted Classification
(127)
LW Dalton - South Austin Hospital, Austin, TX
| Add |
| 11:15 |
Molecular Difference between Pure Ductal Carcinoma In Situ (DCIS) and the DCIS Component of Invasive Ductal Carcinoma
(108)
H Chen, J Wang, B Wei, J Da, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC
| Add |
| 11:30 |
Targeted Overexpression of EZH2 to the Mammary Gland Accelerates ErbB2-Driven Tumorigenesis
(193)
X Li, ME Gonzalez, ML DuPrie, KA Toy, CG Kleer - University of Michigan, Ann Arbor
| Add |
| 11:45 |
LYRIC Is Associated with an Increased Incidence of Distant Metastasis and Loco-Regional Recurrence in Patients with Breast Carcinoma
(96)
JP Bergeron, HT Richard, J Richey, JA Almenara, MO Idowu - Virginia Commonwealth University, Richmond, VA
| Add |
|
|
